Literature DB >> 3888366

Localization of lactoferrin and nonspecific cross-reacting antigen in human breast carcinomas. An immunohistochemical study using the avidin-biotin-peroxidase complex method.

C Charpin, A Lachard, N Pourreau-Schneider, J Jacquemier, M N Lavaut, C Andonian, P M Martin, M Toga.   

Abstract

A retrospective immunocytochemical study was performed on 67 human breast carcinomas to determine whether the epithelial cell-associated antigens, lactoferrin and nonspecific cross-reacting antigen (NCA), could be used as markers in the prognostic assessment of breast cancers. Fixed paraffin sections were tested with anti-lactoferrin and anti-NCA. Lactoferrin and NCA were found in 7.5% and 19% of the cases, respectively. Furthermore, the association between these two antigens in tumor cells was significant (P less than 0.05). Kappa-casein was observed in all antigen-positive cases. These antigens were observed more often in low-grade ductal carcinomas that had positive estrogen and progestin receptors, but no relationship could be established between lactoferrin or NCA and other prognostic indicators, such as histologic type and grade of the tumor, stromal elastosis, or steroid receptors. Although more antigen might have been detected in unfixed, frozen specimens, the results indicate that lactoferrin and NCA possess minimal value as epithelial cell markers and no prognostic value when detected on routinely fixed, paraffin-embedded samples.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3888366     DOI: 10.1002/1097-0142(19850601)55:11<2612::aid-cncr2820551113>3.0.co;2-c

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

1.  Does lactoferrin behave as an immunohistochemical oncofetal marker in bone and cartilage human neoplasms?

Authors:  Antonio Ieni; Valeria Barresi; Maddalena Grosso; Giuseppe Speciale; Michele A Rosa; Giovanni Tuccari
Journal:  Pathol Oncol Res       Date:  2010-10-24       Impact factor: 3.201

2.  Immunoexpression of lactoferrin in triple-negative breast cancer patients: A proposal to select a less aggressive subgroup.

Authors:  Antonio Ieni; Valeria Barresi; Luana Licata; Roberta Cardia; Carmine Fazzari; Giuseppe Nuciforo; Francesco Caruso; Michele Caruso; Vincenzo Adamo; Giovanni Tuccari
Journal:  Oncol Lett       Date:  2017-03-14       Impact factor: 2.967

3.  Immunohistochemical markers in the identification of metastatic breast cancer.

Authors:  P C de Almeida; C B Pestana
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

4.  Multiparametric analysis (SAMBA 200) of the progesterone receptor immunocytochemical assay in nonmalignant and malignant breast disorders.

Authors:  C Charpin; J Jacquemier; L Andrac; H Vacheret; M C Habib; B Devictor; M N Lavaut; M Toga
Journal:  Am J Pathol       Date:  1988-08       Impact factor: 4.307

5.  Kappa casein, lactalbumin and GCDFP 70 localization in human breast carcinomas: an immunohistochemical study using the avidin-biotin-peroxidase complex method.

Authors:  C Charpin; P M Martin; A Lachard; J Jacquemier; M N Lavaut; C Andonian; N Pourreau-Schneider; M Toga
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

6.  Lactoferrin immuno-expression in human normal and neoplastic bone tissue.

Authors:  Antonio Ieni; Valeria Barresi; Maddalena Grosso; Michele Attilio Rosa; Giovanni Tuccari
Journal:  J Bone Miner Metab       Date:  2009-02-26       Impact factor: 2.626

7.  Immunoexpression of lactoferrin in bone metastases and corresponding primary carcinomas.

Authors:  A Ieni; V Barresi; G Branca; G Giuffrè; M A Rosa; G Tuccari
Journal:  Oncol Lett       Date:  2013-03-05       Impact factor: 2.967

8.  Characterization of proteins secreted by pancreatic cancer cells with anticancer drug treatment in vitro.

Authors:  Takanobu Takata; Yasuhito Ishigaki; Takeo Shimasaki; Hideyuki Tsuchida; Yoshiharu Motoo; Akio Hayashi; Naohisa Tomosugi
Journal:  Oncol Rep       Date:  2012-09-05       Impact factor: 3.906

9.  Isolation of a lactoferrin cDNA clone and its expression in human breast cancer.

Authors:  T Campbell; R A Skilton; R C Coombes; S Shousha; M D Graham; Y A Luqmani
Journal:  Br J Cancer       Date:  1992-01       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.